amiodarone has been researched along with Sensitivity and Specificity in 49 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of the study was to assess the diagnostic accuracy of pCLE for amiodarone-related pneumonia (AMR-IP)." | 9.17 | In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia. ( Bergot, E; Bourg-Heckly, G; Dominique, S; Genevois, A; Jounieaux, V; Roussel, F; Salaün, M; Thiberville, L; Vergnon, JM; Vever-Bizet, C; Zalcman, G, 2013) |
| "To determine the incidence and predictability of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH) in patients with cardiomyopathy." | 9.13 | Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism. ( Hofmann, A; Holzmannhofer, J; Nawara, C; Ofluoglu, S; Pirich, C; Strohmer, B, 2008) |
| " A measure of the optimum regression residual (r(opt)) has been calculated, discriminating between post-myocardial infarction patients at high and low risk of arrhythmic death while on treatment with amiodarone." | 9.11 | Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction. ( Caminal, P; de Luna, AB; Laguna, P; Malik, M; Pueyo, E; Smetana, P, 2004) |
| "Distinguishing between amiodarone-induced thyrotoxicosis (AIT) caused by excessive hormone synthesis (AIT-1) or by a destructive process (AIT-2) has important therapeutic implications, but is still difficult and debated." | 7.88 | Amiodarone-Induced Thyrotoxicosis: Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR). ( Barollo, S; Bertazza, L; Bodanza, V; Cavedon, E; Cecchin, D; Censi, S; Gusella, S; Manso, J; Mian, C; Watutantrige-Fernando, S, 2018) |
| "To determine how expert European thyroidologists assess and treat amiodarone-induced thyrotoxicosis (AIT)." | 7.72 | Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. ( Bartalena, L; Bogazzi, F; Lai, A; Martino, E; Piantanida, E; Tanda, ML; Wiersinga, WM, 2004) |
| "To determine the efficacy necessary to make prophylactic ICD or amiodarone therapy cost-effective in patients with myocardial infarction." | 7.71 | Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. ( Every, NR; Heidenreich, PA; Hlatky, MA; McDonald, KM; Owens, DK; Parsons, LS; Sanders, GD, 2001) |
| "Thirty consecutive patients with chronic rheumatic atrial fibrillation (AF) > or = 3 months after successful mitral valve surgery and left atrial diameter < or = 60 mm were treated with oral amiodarone." | 7.68 | Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery. ( Essop, MR; Röthlisberger, C; Sareli, P; Skoularigis, J; Skudicky, D; Wisenbaugh, T, 1993) |
| "Amiodarone therapy, especially chronic, can result in difficult ventricular fibrillation (VF) inductions during implantable cardioverter defibrillator (ICD) testing." | 5.17 | Effectiveness of VF induction with DC fibber versus conventional induction methods in patients on chronic amiodarone therapy. ( Gupta, MS; Kim, MH; Rubenstein, JC, 2013) |
| " The objective of the study was to assess the diagnostic accuracy of pCLE for amiodarone-related pneumonia (AMR-IP)." | 5.17 | In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia. ( Bergot, E; Bourg-Heckly, G; Dominique, S; Genevois, A; Jounieaux, V; Roussel, F; Salaün, M; Thiberville, L; Vergnon, JM; Vever-Bizet, C; Zalcman, G, 2013) |
| "To determine the incidence and predictability of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH) in patients with cardiomyopathy." | 5.13 | Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism. ( Hofmann, A; Holzmannhofer, J; Nawara, C; Ofluoglu, S; Pirich, C; Strohmer, B, 2008) |
| "Analysing the Holter recordings collected at baseline during the European Myocardial Infarction Amiodarone Trial (EMIAT), we evaluate the possibility of using alpha, the slope of the power spectrum of heart rate variability signals (HRV) in the vicinity of f = 0, for postinfarction risk stratification." | 5.12 | HRV scaling exponent identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone. ( Cerutti, S; Hnatkova, K; Malik, M; Sassi, R; Signorini, MG, 2006) |
| " A measure of the optimum regression residual (r(opt)) has been calculated, discriminating between post-myocardial infarction patients at high and low risk of arrhythmic death while on treatment with amiodarone." | 5.11 | Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction. ( Caminal, P; de Luna, AB; Laguna, P; Malik, M; Pueyo, E; Smetana, P, 2004) |
| "The duration, severity, and cause of hypotension after intravenous amiodarone has not been well characterized in anesthetized cardiac surgical patients." | 5.10 | Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. ( Augoustides, JG; Cheung, AT; Gardner, TJ; Harrington, A; Levy, WJ; Savino, JS; Weiss, SJ, 2003) |
| "Despite the antiarrhythmic efficacy of amiodarone, a definitive correlation between amiodarone treatment and increased non-arrhythmic mortality in patients with heart failure and depressed ventricular function has been reported." | 4.80 | Perspectives: does amiodarone increase non-sudden deaths? If so, why? ( Auricchio, A; Klein, HU; Nisam, S, 2000) |
| "Distinguishing between amiodarone-induced thyrotoxicosis (AIT) caused by excessive hormone synthesis (AIT-1) or by a destructive process (AIT-2) has important therapeutic implications, but is still difficult and debated." | 3.88 | Amiodarone-Induced Thyrotoxicosis: Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR). ( Barollo, S; Bertazza, L; Bodanza, V; Cavedon, E; Cecchin, D; Censi, S; Gusella, S; Manso, J; Mian, C; Watutantrige-Fernando, S, 2018) |
| " We evaluated the clinical performance of nine FT4 assays in five centres, using a panel of 310 sera: 156 from euthyroid controls; 27 from hyperthyroid patients; 34 from untreated hypothyroidism; 22 from patients with renal failure; 30 from women in the last trimester of pregnancy; 23 from patients on thyroid substitutive therapy; and 18 from patients treated with amiodarone." | 3.72 | Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. ( Beaudonnet, A; d'Herbomez, M; Forzy, G; Gasser, F; Massart, C; Sapin, R, 2003) |
| "To determine how expert European thyroidologists assess and treat amiodarone-induced thyrotoxicosis (AIT)." | 3.72 | Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. ( Bartalena, L; Bogazzi, F; Lai, A; Martino, E; Piantanida, E; Tanda, ML; Wiersinga, WM, 2004) |
| "To determine the efficacy necessary to make prophylactic ICD or amiodarone therapy cost-effective in patients with myocardial infarction." | 3.71 | Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. ( Every, NR; Heidenreich, PA; Hlatky, MA; McDonald, KM; Owens, DK; Parsons, LS; Sanders, GD, 2001) |
| "We performed a methodological comparison of free triiodothyronine (FT3) estimates in patients with liver cirrhosis and renal failure." | 3.69 | Determination of free triiodothyronine by six different methods in patients with non-thyroidal illness and in patients treated with amiodarone. ( Chambron, J; Christofides, N; Gasser, F; Gervais, A; Kaltenbach, G; Petitjean, P; Roul, G; Sapin, R; Schlienger, JL, 1995) |
| "Three labeled-antibody immunoassays of free triiodothyronine (FT3) were studied in hyperthyroid patients, patients with nonthyroidal illness, and patients being treated with amiodarone; we also studied sera presenting known interferences (n for all groups = 465)." | 3.69 | Clinical comparison of three labeled-antibody immunoassays of free triiodothyronine. ( Cosson, E; d'Herbomez, M; Dilouya, A; Dumont, A; Helal, BO; Le Guillouzic, D; Lebtahi, R; Piketty, ML, 1996) |
| "Thirty consecutive patients with chronic rheumatic atrial fibrillation (AF) > or = 3 months after successful mitral valve surgery and left atrial diameter < or = 60 mm were treated with oral amiodarone." | 3.68 | Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery. ( Essop, MR; Röthlisberger, C; Sareli, P; Skoularigis, J; Skudicky, D; Wisenbaugh, T, 1993) |
| "To compare thyroid imaging using Tc-99m sestamibi with the standard Tc-99m pertechnetate scintigraphy in patients on chronic use of amiodarone." | 2.75 | Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging. ( Amorim, BJ; Camargo, EE; de Almeida, EA; de Oliveira Santos, A; Etchebehere, EC; Guariento, MH; Lima, MC; Oki, GC; Ramos, CD; Tambascia, MA; Zantut-Wittmann, DE, 2010) |
| "Dronedarone was extracted using one-step liquid-liquid extraction." | 1.40 | Pharmacokinetics of dronedarone in rat using a newly developed high-performance liquid chromatographic assay method. ( Brocks, DR; Gabr, RQ; Jardan, YA, 2014) |
| " This novel HPLC method allows the fast and reliable determination of amiodarone and desethylamiodarone from several rat matrices (plasma, liver, kidneys, lungs and heart) and was successfully applied in a preliminary pharmacokinetic study." | 1.39 | A rapid HPLC method for the simultaneous determination of amiodarone and its major metabolite in rat plasma and tissues: a useful tool for pharmacokinetic studies. ( Alves, G; Falcão, A; Ferreira, A; Queiroz, J; Rodrigues, M, 2013) |
| "Phospholipidosis (PLD) is a topic of concern in drug development because it may be associated with toxicological consequences." | 1.37 | Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis. ( Atienzar, FA; Cossu-Leguille, C; Depelchin, O; Dhalluin, S; Gerets, HH; Hanon, E; Tilmant, K; Vasseur, P, 2011) |
| "A dosing algorithm including genetic (VKORC1 and CYP2C9 genotypes) and nongenetic factors (age, weight, therapeutic indication, and cotreatment with amiodarone or simvastatin) explained 51% of the variance in stable weekly warfarin doses in 390 patients attending an anticoagulant clinic in a Brazilian public hospital." | 1.35 | Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients. ( Dias-Neto, E; Ojopi, EB; Perini, JA; Rangel, F; Santana, IS; Silva-Assunção, E; Struchiner, CJ; Suarez-Kurtz, G, 2008) |
| "A rapid method for the quantification of amiodarone and desethylamiodarone in animal plasma using high-performance liquid chromatography combined with UV detection (HPLC-UV) is presented." | 1.33 | Determination of amiodarone and desethylamiodarone in horse plasma and urine by high-performance liquid chromatography combined with UV detection and electrospray ionization mass spectrometry. ( Baert, K; Croubels, S; De Backer, P; De Clercq, D; Deprez, P; Maes, A; van Loon, G, 2006) |
| "Amiodarone is a potent antiarrhythmic agent that is limited in clinical use by its adverse effects, including potentially life threatening amiodarone-induced pulmonary toxicity (AIPT)." | 1.32 | Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity. ( Altaner, S; Altun, A; Berkada, S; Durmus-Altun, G; Ozbay, G; Sami Salihoglu, Y, 2004) |
| "Two simple, sensitive and economical spectrophotometric methods have been developed for the determination of amiodarone hydrochloride in pure form and commercial dosage form." | 1.32 | Validated spectrophotometric methods for the determination of amiodarone hydrochloride in commercial dosage forms using p-chloranilic acid and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. ( Azmi, SN; Khan, NA; Rahman, N, 2004) |
| "Amiodarone (AMI) is a potent antiarrhythmic drug." | 1.31 | Metabolism of amiodarone. II. High-performance liquid chromatographic assay for mono-N-desethylamiodarone hydroxylation in liver microsomes. ( Bigler, L; Follath, F; Ha, HR; Kozlik, P; Stieger, B, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (16.33) | 18.2507 |
| 2000's | 28 (57.14) | 29.6817 |
| 2010's | 13 (26.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passarelli, MK | 1 |
| Pirkl, A | 1 |
| Moellers, R | 1 |
| Grinfeld, D | 1 |
| Kollmer, F | 1 |
| Havelund, R | 1 |
| Newman, CF | 1 |
| Marshall, PS | 1 |
| Arlinghaus, H | 1 |
| Alexander, MR | 1 |
| West, A | 1 |
| Horning, S | 1 |
| Niehuis, E | 1 |
| Makarov, A | 1 |
| Dollery, CT | 1 |
| Gilmore, IS | 1 |
| Censi, S | 1 |
| Bodanza, V | 1 |
| Manso, J | 1 |
| Gusella, S | 1 |
| Watutantrige-Fernando, S | 1 |
| Cavedon, E | 1 |
| Barollo, S | 1 |
| Bertazza, L | 1 |
| Cecchin, D | 1 |
| Mian, C | 1 |
| Kahma, H | 1 |
| Filppula, AM | 1 |
| Launiainen, T | 1 |
| Viinamäki, J | 1 |
| Neuvonen, M | 1 |
| Evangelista, EA | 1 |
| Totah, RA | 1 |
| Backman, JT | 1 |
| Zao, CL | 1 |
| Yang, YC | 1 |
| Tomanek, L | 1 |
| Cooke, A | 1 |
| Berger, R | 1 |
| Chien, LC | 1 |
| Madigan, R | 1 |
| Rubenstein, JC | 1 |
| Gupta, MS | 1 |
| Kim, MH | 1 |
| Jardan, YA | 1 |
| Gabr, RQ | 1 |
| Brocks, DR | 2 |
| Parekh, JM | 1 |
| Sanyal, M | 1 |
| Yadav, M | 1 |
| Shrivastav, PS | 1 |
| Carnicer-Lombarte, A | 1 |
| Lancashire, HT | 1 |
| Vanhoestenberghe, A | 1 |
| Pérez-Ruiz, T | 2 |
| Martínez-Lozano, C | 2 |
| García-Martínez, MD | 1 |
| Perini, JA | 1 |
| Struchiner, CJ | 1 |
| Silva-Assunção, E | 1 |
| Santana, IS | 1 |
| Rangel, F | 1 |
| Ojopi, EB | 1 |
| Dias-Neto, E | 1 |
| Suarez-Kurtz, G | 1 |
| Hofmann, A | 1 |
| Nawara, C | 1 |
| Ofluoglu, S | 1 |
| Holzmannhofer, J | 1 |
| Strohmer, B | 1 |
| Pirich, C | 1 |
| Oki, GC | 1 |
| Zantut-Wittmann, DE | 1 |
| de Oliveira Santos, A | 1 |
| Guariento, MH | 1 |
| Tambascia, MA | 1 |
| de Almeida, EA | 1 |
| Amorim, BJ | 1 |
| Lima, MC | 1 |
| Etchebehere, EC | 1 |
| Camargo, EE | 1 |
| Ramos, CD | 1 |
| Tilmant, K | 1 |
| Gerets, HH | 1 |
| Dhalluin, S | 1 |
| Hanon, E | 1 |
| Depelchin, O | 1 |
| Cossu-Leguille, C | 1 |
| Vasseur, P | 1 |
| Atienzar, FA | 1 |
| Matsubara, K | 1 |
| Sanoh, S | 1 |
| Ohta, S | 1 |
| Kitamura, S | 1 |
| Sugihara, K | 1 |
| Fujimoto, N | 1 |
| Rodrigues, M | 1 |
| Alves, G | 1 |
| Ferreira, A | 1 |
| Queiroz, J | 1 |
| Falcão, A | 1 |
| Salaün, M | 1 |
| Roussel, F | 1 |
| Bourg-Heckly, G | 1 |
| Vever-Bizet, C | 1 |
| Dominique, S | 1 |
| Genevois, A | 1 |
| Jounieaux, V | 1 |
| Zalcman, G | 1 |
| Bergot, E | 1 |
| Vergnon, JM | 1 |
| Thiberville, L | 1 |
| Pollak, PT | 1 |
| You, YD | 1 |
| Cheung, AT | 1 |
| Weiss, SJ | 1 |
| Savino, JS | 1 |
| Levy, WJ | 1 |
| Augoustides, JG | 1 |
| Harrington, A | 1 |
| Gardner, TJ | 1 |
| d'Herbomez, M | 2 |
| Forzy, G | 1 |
| Gasser, F | 2 |
| Massart, C | 1 |
| Beaudonnet, A | 1 |
| Sapin, R | 2 |
| Durmus-Altun, G | 2 |
| Altun, A | 2 |
| Sami Salihoglu, Y | 1 |
| Altaner, S | 1 |
| Berkada, S | 1 |
| Ozbay, G | 1 |
| Rahman, N | 1 |
| Khan, NA | 1 |
| Azmi, SN | 1 |
| Pueyo, E | 1 |
| Smetana, P | 1 |
| Caminal, P | 1 |
| de Luna, AB | 1 |
| Malik, M | 2 |
| Laguna, P | 1 |
| Bartalena, L | 1 |
| Wiersinga, WM | 1 |
| Tanda, ML | 1 |
| Bogazzi, F | 1 |
| Piantanida, E | 1 |
| Lai, A | 1 |
| Martino, E | 1 |
| Aktas, RG | 1 |
| Salihoglu, YS | 1 |
| Yigitbasi, NO | 1 |
| Sassi, R | 1 |
| Cerutti, S | 1 |
| Hnatkova, K | 1 |
| Signorini, MG | 1 |
| Martín, J | 1 |
| Ruiz, E | 1 |
| Maes, A | 1 |
| Baert, K | 1 |
| Croubels, S | 1 |
| De Clercq, D | 1 |
| van Loon, G | 1 |
| Deprez, P | 1 |
| De Backer, P | 1 |
| Shayeganpour, A | 1 |
| Somayaji, V | 1 |
| White, CM | 1 |
| Schlienger, JL | 1 |
| Kaltenbach, G | 1 |
| Christofides, N | 1 |
| Roul, G | 1 |
| Gervais, A | 1 |
| Petitjean, P | 1 |
| Chambron, J | 1 |
| Seidl, K | 1 |
| Hauer, B | 1 |
| Schwick, N | 1 |
| Buechele, T | 1 |
| Schilling, I | 1 |
| Senges, J | 1 |
| Skoularigis, J | 1 |
| Röthlisberger, C | 1 |
| Skudicky, D | 1 |
| Essop, MR | 1 |
| Wisenbaugh, T | 1 |
| Sareli, P | 1 |
| Piketty, ML | 1 |
| Le Guillouzic, D | 1 |
| Lebtahi, R | 1 |
| Cosson, E | 1 |
| Dumont, A | 1 |
| Dilouya, A | 1 |
| Helal, BO | 1 |
| Hannak, D | 1 |
| Scharbert, F | 1 |
| Kattermann, R | 1 |
| Valencia, M | 1 |
| Zapata, V | 1 |
| Bider, A | 1 |
| Pérez-González, M | 1 |
| Lamanna, V | 1 |
| Endoh, Y | 1 |
| Hanai, R | 1 |
| Uto, K | 1 |
| Tanaka, T | 1 |
| Ohta, Y | 1 |
| Kasanuki, H | 1 |
| Ohnishi, S | 1 |
| Auricchio, A | 1 |
| Nisam, S | 1 |
| Klein, HU | 1 |
| Barbosa, EC | 1 |
| Barbosa, PR | 1 |
| Ginefra, P | 1 |
| de Souza Bomfim, A | 1 |
| Boghossian, SH | 1 |
| da Rocha, PJ | 1 |
| Filho, FM | 1 |
| Kohno, N | 1 |
| Yokoyama, A | 1 |
| Kondo, K | 1 |
| Ha, HR | 1 |
| Kozlik, P | 1 |
| Stieger, B | 1 |
| Bigler, L | 1 |
| Follath, F | 1 |
| Michelucci, A | 1 |
| Lazzeri, C | 1 |
| Padeletti, L | 1 |
| Bagliani, G | 1 |
| Colella, A | 1 |
| Sabini, A | 1 |
| Zipoli, R | 1 |
| Costoli, A | 1 |
| Pieragnoli, P | 1 |
| Gensini, GF | 1 |
| Franchi, F | 1 |
| Reithmann, C | 1 |
| Dorwarth, U | 1 |
| Gerth, A | 1 |
| Remp, T | 1 |
| Steinbeck, G | 1 |
| Hoffmann, E | 1 |
| Vernhet, H | 1 |
| Bousquet, C | 1 |
| Durand, G | 1 |
| Giron, J | 1 |
| Senac, JP | 1 |
| Sanders, GD | 1 |
| Hlatky, MA | 1 |
| Every, NR | 1 |
| McDonald, KM | 1 |
| Heidenreich, PA | 1 |
| Parsons, LS | 1 |
| Owens, DK | 1 |
| Kollroser, M | 1 |
| Schober, C | 1 |
| Hanioka, N | 1 |
| Saito, Y | 1 |
| Soyama, A | 1 |
| Ando, M | 1 |
| Ozawa, S | 1 |
| Sawada, J | 1 |
| Saavedra, I | 1 |
| Ortiz, M | 1 |
| Gaete, L | 1 |
| Asenjo, R | 1 |
| Biagini, L | 1 |
| Ohar, JA | 1 |
| Jackson, F | 1 |
| Dettenmeier, PA | 1 |
| Bedrossian, CW | 1 |
| Tricomi, SM | 1 |
| Evans, RG | 1 |
| Larsen, GC | 1 |
| Manolis, AS | 1 |
| Sonnenberg, FA | 1 |
| Beshansky, JR | 1 |
| Estes, NA | 1 |
| Pauker, SG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endoscopic Follow-up of Low Grade Precancerous Bronchial Lesions in High Risk Patients (SELEPREBB1)[NCT00213603] | 365 participants (Actual) | Observational | 2002-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amiodarone and Sensitivity and Specificity
| Article | Year |
|---|---|
[Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 1995 |
Perspectives: does amiodarone increase non-sudden deaths? If so, why?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden; Death, Sudden, Cardiac; Female; Heart Failure; Hu | 2000 |
9 trials available for amiodarone and Sensitivity and Specificity
| Article | Year |
|---|---|
Effectiveness of VF induction with DC fibber versus conventional induction methods in patients on chronic amiodarone therapy.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Defibrillators, | 2013 |
Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Austria; Female; Humans; Hypothyroidism; Incidence; Male; | 2008 |
Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Female; Humans; | 2010 |
In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia.
Topics: Aged; Aged, 80 and over; Amiodarone; Bronchoalveolar Lavage; Bronchoscopy; Female; Fluorescent Dyes; | 2013 |
Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Blood Pressure Determination; Cardiac Output; Coronary A | 2003 |
Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction.
Topics: Adaptation, Physiological; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Causality; Comorbidity; D | 2004 |
HRV scaling exponent identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone.
Topics: Adolescent; Adult; Aged; Algorithms; Amiodarone; Diagnosis, Computer-Assisted; Electrocardiography; | 2006 |
Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Topics: Adult; Aged; Amiodarone; Antigens; Antigens, Neoplasm; Atrial Fibrillation; Biomarkers; C-Reactive P | 2000 |
Early reinitiation of atrial fibrillation following external electrical cardioversion in amiodarone-treated patients.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Combined | 2001 |
38 other studies available for amiodarone and Sensitivity and Specificity
| Article | Year |
|---|---|
The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power.
Topics: Amiodarone; Animals; Cells, Cultured; Dopamine; Equipment Design; Female; gamma-Aminobutyric Acid; G | 2017 |
Amiodarone-Induced Thyrotoxicosis: Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Humans; Male; Middle Aged | 2018 |
Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8.
Topics: Amiodarone; Clopidogrel; Cytochrome P-450 CYP2C8; Gemfibrozil; Glucuronides; Humans; Kinetics; Micro | 2019 |
PCR monitoring of parasitemia during drug treatment for canine Chagas disease.
Topics: Amiodarone; Animals; Chagas Disease; DNA, Kinetoplast; DNA, Protozoan; DNA, Satellite; Dog Diseases; | 2019 |
Pharmacokinetics of dronedarone in rat using a newly developed high-performance liquid chromatographic assay method.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Dronedarone; Liqu | 2014 |
Systematic evaluation of plasma phospholipids for reliable and precise determination of dronedarone and desbutyldronedarone by LC-MS/MS.
Topics: Amiodarone; Chromatography, Liquid; Dronedarone; Mass Spectrometry; Phospholipids; Sensitivity and S | 2014 |
In vitro biocompatibility and electrical stability of thick-film platinum/gold alloy electrodes printed on alumina.
Topics: Alloys; Aluminum Oxide; Amiodarone; Animals; Biocompatible Materials; Cell Survival; Electric Impeda | 2017 |
Simultaneous determination of amiodarone and its metabolite desethylamiodarone by high-performance liquid chromatography with chemiluminescent detection.
Topics: 2,2'-Dipyridyl; Amiodarone; Chromatography, High Pressure Liquid; Coordination Complexes; Humans; Lu | 2008 |
Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Ambulatory Care; Amiodarone; Analysis of Var | 2008 |
Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.
Topics: Amiodarone; Animal Testing Alternatives; Animals; Anti-Arrhythmia Agents; Fluorescent Dyes; Foam Cel | 2011 |
An improved thyroid hormone reporter assay to determine the thyroid hormone-like activity of amiodarone, bithionol, closantel and rafoxanide.
Topics: Amiodarone; Animals; B-Cell Lymphoma 3 Protein; Biological Assay; Bithionol; Cell Line; Endocrine Di | 2012 |
A rapid HPLC method for the simultaneous determination of amiodarone and its major metabolite in rat plasma and tissues: a useful tool for pharmacokinetic studies.
Topics: Amiodarone; Animals; Chromatography, High Pressure Liquid; Drug Stability; Linear Models; Liquid-Liq | 2013 |
Monitoring of hepatic function during amiodarone therapy.
Topics: Administration, Oral; Aged; Amiodarone; Analysis of Variance; Chemical and Drug Induced Liver Injury | 2003 |
Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Chemical Analysis; Female; Humans; Hyperthyroidism; Kidney | 2003 |
Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity.
Topics: Aerosols; Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Diagnosis, Differential | 2004 |
Validated spectrophotometric methods for the determination of amiodarone hydrochloride in commercial dosage forms using p-chloranilic acid and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Benzoquinones; Calibration; Dosage Forms; Molecular Structure; S | 2004 |
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Topics: Amiodarone; Europe; Humans; Iodine Radioisotopes; Radionuclide Imaging; Sensitivity and Specificity; | 2004 |
Use of iodine-123 metaiodobenzylguanidine scintigraphy for the detection of amiodarone induced pulmonary toxicity in a rabbit model: a comparative study with technetium-99m diethyltriaminepenta acetic acid radioaerosol scintigraphy.
Topics: 3-Iodobenzylguanidine; Aerosols; Amiodarone; Animals; Anti-Arrhythmia Agents; Injections, Intravenou | 2005 |
Flow injection chemiluminescent determination of amiodarone in pharmaceutical preparations using photogenerated tris(2,2'-bipyridyl)ruthenium(III).
Topics: Amiodarone; Flow Injection Analysis; Hydrogen-Ion Concentration; Luminescent Measurements; Organomet | 2006 |
Determination of amiodarone and desethylamiodarone in horse plasma and urine by high-performance liquid chromatography combined with UV detection and electrospray ionization mass spectrometry.
Topics: Amiodarone; Animals; Chromatography, High Pressure Liquid; Horses; Reference Standards; Sensitivity | 2006 |
A liquid chromatography-mass spectrometry assay method for simultaneous determination of amiodarone and desethylamiodarone in rat specimens.
Topics: Amiodarone; Animals; Calibration; Chromatography, High Pressure Liquid; Injections, Intravenous; Lin | 2007 |
Is dronedarone effective for the prevention of recurrent atrial fibrillation?
Topics: Amiodarone; Atrial Fibrillation; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blin | 2008 |
Determination of free triiodothyronine by six different methods in patients with non-thyroidal illness and in patients treated with amiodarone.
Topics: Adult; Aged; Amiodarone; Humans; Immunoassay; Liver Cirrhosis; Middle Aged; Renal Insufficiency; Sen | 1995 |
Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery.
Topics: Adult; Amiodarone; Atrial Fibrillation; Chronic Disease; Combined Modality Therapy; Electric Counter | 1993 |
Clinical comparison of three labeled-antibody immunoassays of free triiodothyronine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Autoanalysis; Autoantibodies; Humans; Hypert | 1996 |
Stepwise binary gradient high-performance liquid chromatographic system for routine drug monitoring.
Topics: Amiodarone; Chemical Precipitation; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; I | 1996 |
[Measurement of serum amiodarone by protein precipitation followed by high performance liquid chromatography with ultraviolet detection].
Topics: Amiodarone; Anti-Arrhythmia Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Co | 2000 |
The frequency analysis of signal-averaged ECG of P wave as predictor of efficacy of class III antiarrhythmic drugs to maintain sinus rhythm in recurrent idiopathic atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; | 2001 |
KL-6 as a serum marker for amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Diagnosis, Differentia | 2000 |
Metabolism of amiodarone. II. High-performance liquid chromatographic assay for mono-N-desethylamiodarone hydroxylation in liver microsomes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Biotransformation; Chromatography, High Pressure Liquid | 2001 |
Altered values of heart rate variability in patients with relapse of atrial fibrillation during the first week after electrical cardioversion: preliminary data.
Topics: Aged; Amiodarone; Atrial Fibrillation; Circadian Rhythm; Electric Countershock; Electrocardiography, | 2001 |
Reversible amiodarone-induced lung disease: HRCT findings.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Middle Aged; Pulmonary Fibrosis; Rad | 2001 |
Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benef | 2001 |
Determination of amiodarone and desethylamiodarone in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry with an ion trap detector.
Topics: Amiodarone; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reproducibility of Re | 2002 |
High-performance liquid chromatographic assay for amiodarone N-deethylation activity in human liver microsomes using solid-phase extraction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Humans; Microsomes, Liver; | 2002 |
[Determination of plasma concentration of amiodarone and desethylamiodarone with high pressure liquid chromatography. Preliminary experience].
Topics: Adult; Aged; Amiodarone; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Se | 1992 |
Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis.
Topics: Aged; Amiodarone; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cell Count; Humans; Middle Aged; Predi | 1992 |
Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy.
Topics: Amiodarone; Cost-Benefit Analysis; Costs and Cost Analysis; Death, Sudden, Cardiac; Decision Support | 1992 |